Skip To Main Content

Helping desperately-needed medications reach patients

Close up image of a pile of injectable medications in syringes

If you need surgery, the last thing you would want to hear is that it has to be delayed because there isn't enough medication. For some, though, this was reality. In 2017, Nephron Pharmaceuticals started manufacturing medications on the national drug shortage list. CEO Lou Kennedy knew that helping to provide desperately-needed drugs would be good for patients - and the bottom line. Here’s how they did it.

Find Out More

Was this helpful?
Stay informed. Sign up for our emails.
Subscribe to UPS emails.

Email Examples

Sign up for email offers, insights, and industry news that can help improve your shipping. You can manage your preferences at any time.

News and Insights to help you ship smarter

Service Updates to alert you to severe weather and events impacting operations

Promotions and Offers to help you get the most for your money

Product News to keep you up-to-date on new services, tools, and features